NewGenIvf (NIVF) EPS (Basic) (2024 - 2025)
NewGenIvf (NIVF) posted quarterly EPS (Basic) of $1114.7 for Q3 2025, up 621553.92% YoY from N/an in Q3 2024, and up 124.52% sequentially from -$4546.3 in Q4 2024.
NewGenIvf (NIVF) EPS (Basic) (2024 - 2025) Analysis & Trends
NewGenIvf has disclosed EPS (Basic) across 2 years of filings, most recently posting $1114.7 for Q3 2025.
- In Q3 2025, EPS (Basic) rose 621553.92% year-over-year to $1114.7; the TTM figure through Sep 2025 stood at $1076.5 (changed N/A YoY), while the FY2024 annual figure was -$3971.8, down 137.56% from the prior year.
- EPS (Basic) climbed to $1114.7 in Q3 2025, from -$4546.3 in the prior quarter.
- Over the last five years, EPS (Basic) for NIVF reached as high as $1114.7 in Q3 2025 and fell as low as -$4546.3 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | 8.31 |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | 1.76 |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 8.09 |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 4.08 |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | 0.16 |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 1.67 |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 5.71 |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 0.51 |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | -2.93 |
| 10 | NewGenIvf | 25,304.95 | -1.41 Mn | 524,025.00 | -167.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -167.73 |
| Sep 30, 2025 | 1,114.67 |
| Dec 31, 2024 | -4,560.37 |
| Sep 30, 2024 | -0.18 |